{
    "Trade/Device Name(s)": [
        "HbA1c Control Levels 1 and 2",
        "HbA1c Controls Level 1",
        "HbA1c Controls Level 2"
    ],
    "Submitter Information": "Randox Laboratories Limited",
    "510(k) Number": "K131999",
    "Predicate Device Reference 510(k) Number(s)": [
        "K103099"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "July 26, 2013",
    "Summary Letter Received Date": "June 28, 2013",
    "Submission Date": "June 26, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "HbA1c"
    ],
    "Specimen Type(s)": [
        "Human haemolysed blood"
    ],
    "Specimen Container(s)": [
        "Vial"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Randox Laboratories HbA1c Control Levels 1 and 2 as quality control material for HbA1c testing on clinical chemistry systems",
    "Indications for Use Summary": "For in vitro diagnostic use as quality control material to verify performance of laboratory testing procedures of HbA1c on clinical chemistry systems",
    "fda_folder": "Clinical Chemistry"
}